Among patients who developed AHREs, the mean longest single episode duration was substantially shorter in SGLT2i users compared to nonusers (0.10 hours vs 50.60 hours, p = 0.222), although this difference did not reach statistical significance.
← all excerpts
Association of Sodium-Glucose Cotransporter-2 Inhibitors With Atrial High-Rate Episodes in Patients With Cardiac Implantable Electronic Devices.
1
—
—